Cosmecca Korea’s Pill Shot peeling ampoule, launched in January 2024, has surpassed 10 million cumulative orders by June 2026, with over 7.5 million units sold in 2025 alone. The product’s viral success on TikTok and Instagram Reels demonstrates how ODM capabilities in formulation and market timing can create a global hit. For overseas buyers, this case highlights the growing demand for visually impactful, short-form-content-ready aesthetic products.
Product origin and market insight
The idea for Pill Shot emerged from a chance encounter at a Seoul cafe, where Cosmecca Korea sales team leader Geonseok Kim overheard industry professionals discussing competitors. After approaching them, Kim proposed a product concept targeting the shift in global beauty marketing: consumers now discover products through short-form video, not ingredient lists. The result was a collaboration with derma brand Dr. Melaxin, leading to a peeling ampoule designed to deliver instant visible results within 15 seconds.
Formulation breakthrough
Senior researcher Inyoung Na faced the challenge of creating a watery ampoule that could still produce a strong peeling effect. Most peeling gels are thick and require prolonged rubbing, but Pill Shot needed to be dispensed with a dropper and show immediate dead-skin removal. After more than 300 experiments, Na achieved a formulation that transforms upon skin contact, forming small clumps that mimic exfoliation while minimizing irritation. This technical feat is a key differentiator for ODM buyers seeking novel textures.
Sales trajectory and channel dynamics
Pill Shot remained relatively unknown in Korea but exploded overseas via TikTok and Instagram Reels. Sales surged from mid-2025, with 7.5 million units sold that year—over 70% of total volume. Industry benchmarks consider 1 million units per year a hit, making Pill Shot a mega hit. The product’s success underscores the importance of aligning formulation with short-form content virality, a factor increasingly critical for distributors and clinics targeting social-media-driven consumers.
What buyers should watch
For importers and distributors, Pill Shot’s trajectory offers lessons in product-market fit: a visually dramatic, easy-to-demonstrate ampoule that leverages platform algorithms. Cosmecca Korea’s ability to bridge sales insight and R&D execution is a model for ODM sourcing. Buyers evaluating similar products should prioritize formulations that deliver instant visible effects without compromising skin safety, as well as suppliers with proven scale-up capability—Cosmecca Korea’s central research lab in Pangyo handled the complex production.
Regulatory and channel signals
The product’s success outside Korea highlights the importance of global regulatory compliance for novel cosmetic formats. While the article does not specify approvals, the rapid overseas adoption suggests the formulation meets key market standards. Distributors should verify that any peeling ampoule with similar transformative properties aligns with local cosmetic regulations, especially regarding exfoliation claims and ingredient safety.
Source: Read the original report | Published: June 11, 2026